Phthalates Under Scrutiny Again As Study Links the Chemical to Lupus in Mice
The chemical compound known as phthalate It has been a rather bad couple of months for the chemical compound known as phthalate. Following closely on the news that the substance has been linked to reproductive abnormalities in humans come the results of another study that suggest a connection between the chemical and lupus. Lupus … [Read more...]
Physician-Owned Distributorships under Federal Scrutiny
Physician-Owned Distributorships Incentive For Doctors To Give Preference To Devices. A recent report issued by the U.S. Senate's Finance Committee Physician-owned distributorships give incentive for doctors, Mass Device reports. In 2011, a Senate Finance panel report encouraged a group of senators to petition the U.S. Health and … [Read more...]
Frackers Face More Scrutiny in New York
More Frackers Receive Subpoena. New York Attorney General Eric Schneiderman is taking on the hydraulic fracturing industry again, apparently opening a probe into methods the drillers use to value their natural gas discoveries. According to a report from The New York Times, Schneiderman subpoenaed Range Resources Corp., Goodrich … [Read more...]
Infuse Bone Graft Study Conducted At Walter Reed Draws Scrutiny
Infuse Bone Graft Contains Recombinant human Bone Morphogenetic Protein. Another study of Medtronic Inc.'s Infuse Bone Graft product that involved soldiers at Walter Reed Army Medical Center is coming under fire. According to a report in the Minneapolis Star Tribune, Dr. Charles Rosen, president of the Association for Medical Ethics, … [Read more...]
Drug Trials Involving Kids Need More Monitoring
Drug Trials Involving Kids Drug clinical trials involving children don't get enough scrutiny, a new study says. According to experts at Great Britain’s University of Nottingham, the method and processes in which drug trials are conducted in children require more and stricter monitoring and more needs to be done to ensure the … [Read more...]
Ketek Faces More Scrutiny
Ketek Faces More Scrutiny. Lawmakers investigating the defective drug Ketek have been forced to subpoena current and former Food & Drug Administration (FDA) officials. A subcommittee of the House Energy and Commerce Committee is trying to figure out how Ketek, one of the most dangerous antibiotics on the market, obtained FDA … [Read more...]
Morgellons Disease to Get CDC Scrutiny
Morgellons Disease, a Mysterious Skin Ailment Is Now The Subject Of A National Study. Morgellons disease, a mysterious skin ailment that some doctors aren’t even sure is a real disease, is now the subject of a national study. On Wednesday, the Centers for Disease Control and Prevention (CDC) began a study—in collaboration with … [Read more...]
Drug Coated Stents to Get More Scrutiny from FDA Prior to Approval
Drug Coated Stents Are Being Scrutinized. Drug Coated Stents will soon be subject to more stringent testing requirements. The U.S. Food and Drug Administration (FDA) is planning to release new testing requirements for drug-coated heart stents in the next few weeks, the regulatory agency's device chief, Daniel Schultz, told the Wall … [Read more...]
Controversial Antibiotic Ketek Will Face More FDA Scrutiny
Controversial Antibiotic Ketek. As antibiotics go, Ketek has had a pretty high profile. Sen. Chuck Grassley, R-Iowa, tried in vain last week to block Andrew von Eschenbach's confirmation as Food and Drug Administration commissioner, partly because of what the senator views as FDA efforts to hinder his investigation of clinical trials … [Read more...]
Articles Renew Scrutiny of Antianemia
Antianemia Drug Safety Questioned. A set of articles to be published today in the New England Journal of Medicine is spurring new scrutiny of the use of antianemia drugs to boost red blood cell counts beyond Food and Drug Administration recommendations. The FDA said yesterday it will review new data from one of the … [Read more...]
Defective Drug Under Scrutiny
Drug Under Scrutiny. A hyperactivity drug linked last year to deaths, strokes and heart attacks in dozens of patients is expected to face new scrutiny next week when a government advisory committee considers how to study the safety of such medications. A Food and Drug Administration advisory committee will meet Feb. 9 and 10 to … [Read more...]
ADHD Drug Under Scrutiny
ADHD Drug Could Be Unsafe. Parents whose children take Adderall XR for Attention-Deficit Hyperactivity Disorder (ADHD) face a dilemma :whether to let their kids stay on a medicine that could be unsafe when experts say there is a lack of long-term research to guide the decision. The popular drug, which has been linked to 20 sudden … [Read more...]
Docs Wrote Reviews For Drugs Made By Employers
Docs Wrote Reviews For Drugs Made By Employers. The prestigious New England Journal of Medicine violated its own conflict-of-interest policy when it allowed two doctors with financial ties to Merck & Co. to tout COX-2 inhibitor such as Merck's Vioxx while downplaying their heart risks in an August 2001 paper, the Herald has … [Read more...]
HealthSouth’s Scuttled Spinoff Draws New Scrutiny
HealthSouth’s Scuttled Spinoff. For some top officials at HealthSouth even those with a tolerance for Alabama heat last August must have felt like one of the most sweltering months on record. HealthSouth began the month by dazzling Wall Street with a final upside surprise. But company insiders had plenty of reason to sweat. By … [Read more...]
